Intravenous immunoglobulin for the acute treatment of refractory optic neuritis in Japan
This study demonstrates that IVIG may be an effective new option for acute treatment of steroid-resistant ON as an add-on to conventional therapy.
Authors
- Sonoko Tatsui
- Keigo Shikishima
- Takeshi Kezuka (ORCID: https://orcid.org/0000-0002-8141-5077)
- Akiko Yamagami
- Hideki Chuman
- Hitoshi Ishikawa (ORCID: https://orcid.org/0000-0002-0046-9787)
- Nobuyuki Shoji (ORCID: https://orcid.org/0000-0002-3719-0376)
- Y Takahashi (ORCID: https://orcid.org/0009-0008-6751-1186)
- Makoto Nakamura (ORCID: https://orcid.org/0000-0002-6464-4302)
- Masato Hashimoto (ORCID: https://orcid.org/0000-0003-2219-1058)
- Satoshi Ueki (ORCID: https://orcid.org/0000-0002-7199-6111)
- Akiko Kimura (ORCID: https://orcid.org/0000-0002-3099-5761)
Institutions
- Jikei University School of Medicine (JP)
- University of Miyazaki (JP)
- Tokyo Medical University (JP)
- Nakamura Memorial Hospital (JP)
- Inouye Eye Hospital (JP)
- Tokyo Women's Medical University Adachi Medical Center (JP)
- Tokyo Women's Medical University (JP)
- Kitasato University (JP)
- Kobe University (JP)
- Niigata University (JP)
- Hyogo University (JP)
Publication Details
- Journal
- Japanese Journal of Ophthalmology
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1007/s10384-025-01210-6
- Citations
- 1
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47